Michael Hughes
@mshughes_md
Hematology-Oncology fellow at Columbia University, by way of Johns Hopkins Bayview and Harvard Medical School. Classics major. Thoughts/opinions my own.
ID: 1670910607749464071
19-06-2023 21:45:29
55 Tweet
53 Takipçi
162 Takip Edilen
#ASH24 sitting nearby Raj Chakraborty -- the room was too packed with people learning from Suzanne Lentzsch, MD, PhD, Dr Gertz of Mayo Clinic, and Vaishali Sanchorawala re modern treatments for AL amyloidosis!
#ASH24 Metodi Balev presenting important multi site real world data of tec -- excellent ORR and survival outcomes in a sicker than trial population! Raj Chakraborty Suzanne Lentzsch, MD, PhD Divaya Bhutani Herbert Irving Comprehensive Cancer Center
Also congratulations to the one and only Alexandra Rojek for not one but TWO ASH abstract awards!!
Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma #mmsm International Myeloma Foundation Multiple Myeloma RF HealthTree Foundation The Leukemia & Lymphoma Society sanofi.com/en/media-room/…
Brisk hematologic and cardiac organ response in a patient with Cardiac Monoclonal Immunoglobulin Deposition Disease treated with elranatamab! tinyurl.com/mt852vmn Divaya Bhutani Suzanne Lentzsch, MD, PhD Herbert Irving Comprehensive Cancer Center ColumbiaCardiology
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis (15 patients from a collective database of >2000 patients Università di Pavia & Herbert Irving Comprehensive Cancer Center)➡️Good organ response achievable after deep hematologic response, and lung transplant was feasible in one patient! Led by
Another fun and enlightening ASCO with friends and colleagues Michael Hughes Kristine Lacuna, MD Lindor Qunaj Herbert Irving Comprehensive Cancer Center
To hear Suzanne Lentzsch, MD, PhD and myself on a related topic (high-risk #MYELOMA) in our recent Journal of Clinical Oncology Editorial Fellow podcast: music.youtube.com/watch?v=iHockd… Herbert Irving Comprehensive Cancer Center
Results from 4 pivotal phase 3 trials (MIDAS, PERSEUS, IsKIA, ADVANCE) representing current thinking on the role of ASCT in NDMM, masterfully summarized and contextualized by Suzanne Lentzsch, MD, PhD! #ASCO25 #MYELOMA #MRD Herbert Irving Comprehensive Cancer Center
A splendid study by a dear friend and tremendous colleague! Michael May Herbert Irving Comprehensive Cancer Center Gulam Abbas Manji #ASCO25
In another multicenter (Herbert Irving Comprehensive Cancer Center and Brigham and Women's Hospital) study of BCMA BsAb in AL Amyloidosis (including stage IIIb), brisk and deep hematologic responses translating into organ responses, despite short follow-up! Now we need: Prospective data Long term follow up to test
Still have questions about that new 2025 IMS-IMWG definition of high risk #myeloma? Listen to a brief recap + Q&A on the paper at Journal of Clinical Oncology Article Insights I recorded with Nikhil C. Munshi, MD! ascopubs.org/do/jco-article… Herbert Irving Comprehensive Cancer Center Dana-Farber